The p53 codon 72 (Arg72Pro) polymorphism is associated with the degree of insulin resistance in type 2 diabetic subjects: A cross-sectional study

Acta Diabetologica

Volumn 50, Issue 3, 2013, Pages 429-436

  Bonfigli, Anna Rita ^a   Sirolla, Cristina ^a   Testa, Roberto ^a   Cucchi, Michela ^a   Spazzafumo, Liana ^a   Salvioli, Stefano ^b   Ceriello, Antonio ^c,d   Olivieri, Fabiola ^a,e   Festa, Roberto ^e   Procopio, Antonio Domenico ^a,e   Brandoni, Gabriele ^a   Boemi, Massimo ^a   Marra, Maurizio ^a   Franceschi, Claudio ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Diabetes mellitus, type 2; HOMA IR, insulin resistance; p53 polymorphism codon 72; Tumor suppressor protein p53

Indexed keywords

GLUCOSE; INSULIN;

AGED; ARTICLE; BODY MASS; CODON; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; CODON; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FASTING; FEMALE; GENOTYPE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84879199886     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-012-0450-x     Document Type: Article

References (25)

1. Green DR, Chipuk JE (2006) p53 and metabolism: inside the TIGAR. Cell 126:30-32
2. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K et al (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126:107-120
3. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M et al (2006) p53 regulates mitochondrial respiration. Science 312:1650-1653
4. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P et al (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126:121-134
5. Vousden KH, Ryan KM (2009) p53 and metabolism. Nat Rev Cancer 9:691-700
6. Minamino T, Orimo M, Shimizu I, Kunieda T, Yokoyama M et al (2009) A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 15:1082-1087
7. Thomas M, Kalita A, Labrecque S, Pim D, Ban L (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092-1100
8. Bonafé M, Salvioli S, Barbi C, Trapassi C, Tocco F et al (2004) The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischemia-induced cell death. Cell Death Differ 11:962-973
9. Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H et al (2006) iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 38:1133-1141
10. Jeong BS, Hu W, Belyi V, Rabadan R, Levine AJ (2010) Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis. FASEB J 24:1347-1353
11. Molina V, Papiol S, Sanz J, Rosa A, Arias B et al (2011) Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients. Neuroimage 56:45-51
12. Gomez-Sanchez JC, Delgado-Esteban M, Rodriguez-Hernandez I, Sobrino T, Perez de la Ossa N et al (2011) The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke. J Exp Med 208:429-437
13. Gaulton KJ, Willer CJ, Li Y, Scott LJ, Conneely KN et al (2008) Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes 57:3136-3144
14. Burgdorf KS, Grarup N, Justesen JM, Harder MN, Witte DR et al (2011) Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55, 521 Europeans. PLoS One 6:e15813
15. American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1):S62-S69
16. Bonafè M, Olivieri F, Mari D, Baggio G, Mattace R et al (1999) p53 codon 72 polymorphism and longevity: additional data on centenarians from continental Italy and Sardinia. Am J Hum Genet 65:1782-1785
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
18. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modelling. Diabetes Care 27:1487-1495
19. Gallwitz B, Kazda C, Kraus P, Nicolay C, Schernthaner G, Acta Diabetol (2011) Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetes. Acta Diabetol. doi: 10.1007/s00592-011-0319-4
20. Oda E (2012) Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol 49:89-95
21. Kanat M, Norton L, Winnier D, Jenkinson C, DeFronzo RA et al (2011) Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose. Acta Diabetol 48:209-217
22. Qu L, He B, Pan Y, Xu Y, Zhu C et al (2011) Association between polymorphisms in RAPGEF1, TP53, NRF1 and type 2 diabetes in Chinese Han population. Diabetes Res Clin Pract 91:171-176
23. Bojesen SE, Nordestgaard BG (2008) The common germline Arg72Pro polymorphism of p53 and increased longevity in humans. Cell Cycle 15:158-163
24. van Heemst D, Mooijaart SP, Beekman M, Schreuder J, de Craen AJ et al (2005) Variation in the human TP53 gene affects old age survival and cancer mortality. Exp Gerontol 40:11-15
25. Paolisso G, Barbieri M, Rizzo MR, Carella C, Rotondi M et al (2001) Low insulin resistance and preserved beta-cell function contribute to human longevity but are not associated with TH-INS genes. Exp Gerontol 37:149-156